TY - JOUR
T1 - Molecular pharmacology of 5-HT1D recognition sites
T2 - Radioligand binding studies in human, pig and calf brain membranes
AU - Waeber, C.
AU - Schoeffter, P.
AU - Palacios, J. M.
AU - Hoyer, D.
PY - 1988/6
Y1 - 1988/6
N2 - 1) The binding characteristics of [3H]5-HT (5-hydroxytryptamine, serotonin) were investigated in membrane preparations of several regions from calf, pig and human brain in the presence of 100 nmol/l 8-OH-DPAT (8-hydroxy-2[di-n-dipropylamino]tetralin) and 100 nmol/l mesulergine in order to mask 5-HT1A and 5-HT1C sites. 2) [3H]5-HT bound rapidly, reversibly and stereo-selectively to a population of high affinity recognition sites in membranes from pig caudate, calf caudate and human cortex, caudate and substantia nigra. 3) Saturation experiments carried out with [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and 100 nmol/l mesulergine revealed that non-5-HT1A non-5-HT1C sites represented from 50 to more than 90% of the total 5-HT1 sites (determined with [3H]5-HT in the absence of 8-OHDPAT and mesulergine), depending on the tissue source. 4) The pharmacological profile of these sites was characterized in competition experiments performed with a variety of ligands in membranes of calf, pig and human caudate membranes. Under these conditions, [3H]5-HT labelled a population of "5-HT1-like" sites which display nanomolar affinity for tryptamines (5-carboxamidotryptamine > 5-HT >- 5-methoxytryptamine > tryptamine) and some ergolines (metergoline > methysergide). In contrast, these sites showed low affinity for drugs with high affinity and/or selectivity for 5-HT1A (8-OH-DPAT, buspirone), 5-HT1B (21-009, RU 24969), 5-HT1C (mesulergine, mianserin) and 5-HT2 sites (ketanserin, cinanserin). 5) Non-5-HT1A non-5-HT1C sites from calf, pig and human caudate membranes displayed a closely similar affinity profile as illustrated by the statistically very significant correlation parameters obtained when they were compared to one another. The pharmacological profile of these sites is different from that of 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 sites but is consistent with the pharmacology of a "5-HT1-like" receptor. It is very similar to that of the 5-HT1D site recently described in bovine brain by Heuring and Peroutka (1987). 6) The present findings demonstrate the presence and the pharmacological similarity of 5-HT1D sites in pig, calf and human brain.
AB - 1) The binding characteristics of [3H]5-HT (5-hydroxytryptamine, serotonin) were investigated in membrane preparations of several regions from calf, pig and human brain in the presence of 100 nmol/l 8-OH-DPAT (8-hydroxy-2[di-n-dipropylamino]tetralin) and 100 nmol/l mesulergine in order to mask 5-HT1A and 5-HT1C sites. 2) [3H]5-HT bound rapidly, reversibly and stereo-selectively to a population of high affinity recognition sites in membranes from pig caudate, calf caudate and human cortex, caudate and substantia nigra. 3) Saturation experiments carried out with [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and 100 nmol/l mesulergine revealed that non-5-HT1A non-5-HT1C sites represented from 50 to more than 90% of the total 5-HT1 sites (determined with [3H]5-HT in the absence of 8-OHDPAT and mesulergine), depending on the tissue source. 4) The pharmacological profile of these sites was characterized in competition experiments performed with a variety of ligands in membranes of calf, pig and human caudate membranes. Under these conditions, [3H]5-HT labelled a population of "5-HT1-like" sites which display nanomolar affinity for tryptamines (5-carboxamidotryptamine > 5-HT >- 5-methoxytryptamine > tryptamine) and some ergolines (metergoline > methysergide). In contrast, these sites showed low affinity for drugs with high affinity and/or selectivity for 5-HT1A (8-OH-DPAT, buspirone), 5-HT1B (21-009, RU 24969), 5-HT1C (mesulergine, mianserin) and 5-HT2 sites (ketanserin, cinanserin). 5) Non-5-HT1A non-5-HT1C sites from calf, pig and human caudate membranes displayed a closely similar affinity profile as illustrated by the statistically very significant correlation parameters obtained when they were compared to one another. The pharmacological profile of these sites is different from that of 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-HT3 sites but is consistent with the pharmacology of a "5-HT1-like" receptor. It is very similar to that of the 5-HT1D site recently described in bovine brain by Heuring and Peroutka (1987). 6) The present findings demonstrate the presence and the pharmacological similarity of 5-HT1D sites in pig, calf and human brain.
KW - 5-HT
KW - 5-HT
KW - 5-HT
KW - 5-HT sites
KW - [H]5-HT binding
KW - Human
KW - Pig and calf brain
UR - https://www.scopus.com/pages/publications/0023751489
U2 - 10.1007/BF00175783
DO - 10.1007/BF00175783
M3 - Article
C2 - 2975354
AN - SCOPUS:0023751489
SN - 0028-1298
VL - 337
SP - 595
EP - 601
JO - Naunyn-Schmiedeberg's Archives of Pharmacology
JF - Naunyn-Schmiedeberg's Archives of Pharmacology
IS - 6
ER -